Sample size for biomarker studies: More subjects or more measurements per subject?

Annals of Epidemiology

Volumn 13, Issue 3, 2003, Pages 204-208

  Lai, Dejian ^a   King, Terri M ^b   Moyé, Lemuel A ^a   Wei, Qingyi ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Financial Constraints; Optimal Design; Repeated Measurement

Indexed keywords

BIOLOGICAL MARKER;

AGING; ARTICLE; BASAL CELL CARCINOMA; BIOAVAILABILITY; CONTROLLED STUDY; COST; DNA REPAIR; HUMAN; MEASUREMENT; MOLECULAR BIOLOGY; PILOT STUDY; PRIORITY JOURNAL; SAMPLING; STATISTICAL ANALYSIS;

ADULT; AGED; AGING; BIOLOGICAL MARKERS; CARCINOMA, BASAL CELL; COST CONTROL; DNA REPAIR; EPIDEMIOLOGIC STUDIES; HUMANS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 0242669989     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(02)00261-2     Document Type: Article

References (23)

1. Cox D.R. Planning of Experiments. 1958;John Wiley, New York.
2. Athas W.F., Hedayati M.A., Matanoski G.M., Farmer E.R., Grossman L. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res. 51:1991;5786-5793.
3. Wei Q., Matanoski G.M., Farmer E.R., Hedayati M.A., Grossman L. DNA repair and aging in basal cell carcinoma. a molecular epidemiology study Proc Natl Acad Sci USA. 90:1993;1614-1618.
4. Peterson R.G. Design and Analysis of Experiments. 1985;Marcel Dekker, New York.
5. Milliken G.A., Johnson D.E. Analysis of Messy Data. 1984;Van Nostrand Reinhold, New York.
6. Perera F.P. Molecular epidemiology. Insight into cancer susceptibility, risk assessment, and prevention J Natl Cancer Inst. 88:1996;496-509.
7. Breslow N.E., Day N.E. Statistical Methods in Cancer Research, Vol. 1. Analysis of Case-Control Studies. 1980;International Agency for Research on Cancer, Lyon.
8. Schlesselman J.J. Case-Control Studies. Design, Conduct, Analysis:1982;Oxford University Press, New York.
9. Moyè L.A. Central laboratory sampling plans and quality control in clinical trials. Control Clin Trials. 12:1991;761-767.
10. Cochran W.G. Sampling Techniques. 3rd ed:1977;John Wiley, New York.
11. Prentice R.L. Design issues in cohort studies. Stat Methods Med Res. 4:1995;273-292.
12. Wacholder S. Design issues in case-control studies Stat. Methods Med Res. 4:1995;293-310.
13. Wickramaratne P.J. Sample size determination in epidemiologic studies. Stat Methods Med Res. 4:1995;311-338.
14. Rochon J. Sample size calculations for two-group repeated-measure experiments. Biometrics. 47:1991;1383-1398.
15. Overall J.E., Doyle S.R. Estimating sample sizes for repeated measurement designs. Control Clin Trials. 15:1994;100-123.
16. Kirby A.J., Galai N., Munoz A. Sample size estimation using repeated measurements on biomarkers as outcomes. Control Clin Trials. 15:1994;165-172.
17. Hornberger J.C., Brown B.W.M., Halpern J. Designing a cost-effective clinical trial. Stat Med. 14:1995;2249-2259.
18. Torgerson D.J., Ryan M., Ratcliffe J. Economics in sample size determination for clinical trials. QJM. 88:1995;517-521.
19. Rao C.R. Linear Statistical Inference and Its Applications. 2nd ed:1973;John Wiley, New York.
20. Hedayat A.S., Jacroux M., Majumdar D. Optimal designs for comparing test treatment with controls (with comments). Stat Sci. 3:1989;462-491.
21. Wei Q., Cheng L., Hong W.K., Spitz M.R. Reduced DNA-repair capacity in lung cancer patients. Cancer Res. 56:1996;4103-4107.
22. Raudenbush S.W., Liu X.F. Statistical power and optimal design for multisite randomized trials. Psychol Methods. 5:2000;199-213.
23. Brunier H.C., Whitehead J. Sample size for phase II clinical trials derived from Bayesian decision theory. Stat Med. 13:1994;2493-2502.